Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Laboratorio Pasteur S.A., commonly referred to as Pasteur, is a prominent player in the pharmaceutical and biotechnology industry, headquartered in Chile (CL). Established in 1992, the company has made significant strides in the development and production of high-quality pharmaceutical products, particularly in the fields of vaccines and biopharmaceuticals.
With a strong operational presence across Latin America, Laboratorio Pasteur S.A. is renowned for its commitment to innovation and quality. The company’s core offerings include a diverse range of vaccines and therapeutic solutions, distinguished by their rigorous research and development processes. Pasteur's dedication to excellence has positioned it as a trusted name in the healthcare sector, achieving notable milestones in both product development and market expansion.
-25 vs industry average
Laboratorio Pasteur S.A.’s score of 17 is lower than 41% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Laboratorio Pasteur S.A. yet.
Laboratorio Pasteur S.A., headquartered in Chile (CL), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Laboratorios Sanfer, SA de CV, which may influence its climate commitments and performance metrics.
Despite the lack of direct emissions data, Laboratorio Pasteur S.A. is part of a corporate family that may have established climate initiatives. However, no specific reduction targets or commitments have been documented for Laboratorio Pasteur S.A. itself, nor are there any climate pledges reported.
As a subsidiary, it is essential to consider the broader context of its parent company, Laboratorios Sanfer, SA de CV, for insights into potential climate strategies and performance. The absence of specific data highlights the need for transparency and accountability in emissions reporting within the pharmaceutical industry, particularly as companies increasingly face pressure to disclose their environmental impact and set ambitious reduction targets.
No climate goals have been disclosed for Laboratorio Pasteur S.A. yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Laboratorio Pasteur S.A. yet.
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more